XNAS · JAGX
-1.66% · -$0.0400 · Vol 35.5K
After hours · updated 16:00:00 ET
Jaguar Health, Inc.

Jaguar Health, Inc.

PHARMACEUTICAL PREPARATIONS
$2.37
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is JAGX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Jaguar Health, Inc.
PHARMACEUTICAL PREPARATIONS
Listed since
2015
Employees
47
Country
US

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.44
Day high
$2.44
Day low
$2.17
Previous close
$2.41
52W high
$3.05
-22.30% from high
52W low
$2.17
23% of range
Market cap
$11.7M
EPS
$-46.8400
Shares out
4.9M
Volume
35.5K
VWAP
$2.28
Price history computed in-house
1W
-12.87%
1M
-13.82%
SMA 50 $2.62 · below
SMA 200 $2.62 · below
52W position 23%
Veridion warehouse edge

Warehouse intelligence for JAGX.

Veridion Score
31
0: 951: 312: 133: 104: 825: 50
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

JAGX insider activity

Jaguar Health, Inc.

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for JAGX.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

JAGX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for JAGX in this window.
Lobbying spend

JAGX lobbying filings, year to date.

Registered lobbying filings matched to Jaguar Health, Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for JAGX in this window.
Latest news · JAGX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for JAGX.
Options
Sovereign unlock shows live options positioning for JAGX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.